UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$80.26K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 17, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$497.27
Sep 17, 2026
Close before public filing
$497.27
Sep 17, 2026
Return since public filing
-0.53%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 160 shares @ $501.6
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000144
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$5.83M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 17, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $295.44K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $865.1K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $943.18K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $1.08M |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $970.98K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $75.17K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $165.7K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $234.04K |
| United Therapeutics Corp UTHR Current | Sale | Sep 17, 2026 | $80.26K |
| United Therapeutics Corp UTHR | Exercise | Sep 17, 2026 | $0 |